A carregar...

PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis

The clinical efficacy of tyrosine kinase inhibitors supports the dependence of distinct subsets of cancers on specific driver mutations for survival, a phenomenon called “oncogene addiction.” We demonstrate that PUMA and BIM are the key apoptotic effectors of tyrosine kinase inhibitors in breast can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bean, Gregory R., Ganesan, Yogesh Tengarai, Dong, Yiyu, Takeda, Shugaku, Liu, Han, Chan, Po M., Huang, Yafen, Chodosh, Lewis A., Zambetti, Gerard P., Hsieh, James J.-D., Cheng, Emily H.-Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753585/
https://ncbi.nlm.nih.gov/pubmed/23532334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.2003483
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!